Press Release: Transition Therapeutics : New Study: Transition Therapeutics Inc. (TTH) - Financial and Strategic SWOT Analysis Review

(PR-inside.com) Summary Transition Therapeutics Inc. (Transition) is a biopharmaceutical company that develops medicines for the treatment of CNS disorders, Alzheimer's disease and diabetes. The company is developing drugs for the treatment of aggression associated with Down syndrome and Alzheimer's disease. It is also developing a metabolic drug candidate for the treatment of type two diabetes and accompanying obesity. Transition is also currently conducting clinical trials on several upcoming drugs for the treatment of various diseases. It partners with various other biopharmaceutical companies to market its products.Transition is headquartered in Toronto, Ontario, Canada. Transition Therapeutics Inc. Key Recent Developments Jun 03, 2016: Transition Therapeutics Receives ..